Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors

被引:0
作者
Barbara Rivera
Tenzin Gayden
Jian Carrot-Zhang
Javad Nadaf
Talia Boshari
Damien Faury
Michele Zeinieh
Romeo Blanc
David L. Burk
Somayyeh Fahiminiya
Eric Bareke
Ulrich Schüller
Camelia M. Monoranu
Ronald Sträter
Kornelius Kerl
Thomas Niederstadt
Gerhard Kurlemann
Benjamin Ellezam
Zuzanna Michalak
Maria Thom
Paul J. Lockhart
Richard J. Leventer
Milou Ohm
Duncan MacGregor
David Jones
Jason Karamchandani
Celia M. T. Greenwood
Albert M. Berghuis
Susanne Bens
Reiner Siebert
Magdalena Zakrzewska
Pawel P. Liberski
Krzysztof Zakrzewski
Sanjay M. Sisodiya
Werner Paulus
Steffen Albrecht
Martin Hasselblatt
Nada Jabado
William D. Foulkes
Jacek Majewski
机构
[1] McGill University,Program in Cancer Genetics, Department of Oncology and Human Genetics
[2] McGill University,Department of Human Genetics
[3] McGill University and Génome Québec Innovation Centre,Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital
[4] McGill University,Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research, Jewish General Hospital
[5] McGill University,Department of Biochemistry and Groupe de Recherche Axé sur la Structure des Protéines
[6] McGill University,Center for Neuropathology
[7] Ludwig-Maximilians-University,Department of Neuropathology, Institute of Pathology, Comprehensive Cancer Center Mainfranken
[8] University of Würzburg,Pediatric Hematology and Oncology
[9] University Children’s Hospital Münster,Department of Radiology
[10] University Hospital Münster,Division of Pediatric Neurology
[11] University Children’s Hospital,Department of Pathology
[12] CHU Sainte-Justine,Division of Neuropathology
[13] UCL Institute of Neurology,Department of Clinical and Experimental Epilepsy
[14] UCL Institute of Neurology,Department of Pediatrics
[15] The University of Melbourne,Bruce Lefroy Centre for Genetic Health Research
[16] Murdoch Childrens Research Institute,Department of Neurology
[17] The Royal Children’s Hospital,Department of Anatomical Pathology
[18] Murdoch Childrens Research Institute,German Cancer Consortium (DKTK)
[19] VUMC School of Medical Sciences,Division of Pediatric Neurooncology (B062)
[20] Royal Children’s Hospital,Department of Pathology, Montreal Neurological Institute
[21] German Cancer Research Center (DKFZ),Departments of Oncology and Epidemiology, Biostatistics and Occupational Health
[22] German Cancer Research Center (DKFZ),Institute of Human Genetics
[23] McGill University,Department of Molecular Pathology and Neuropathology
[24] McGill University,Department of Neurosurgery
[25] Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein,Institute of Neuropathology
[26] Medical University of Lodz,Department of Pathology, Montreal Children’s Hospital, McGill University Health Centre
[27] Polish Mother’s Memorial Hospital Research Institute,Department of Pediatrics, Montreal Children’s Hospital
[28] Epilepsy Society,Department of Medical Genetics and Cancer Research Program
[29] University Hospital Münster,undefined
[30] McGill University,undefined
[31] McGill University Health Centre,undefined
[32] Research Institute McGill University Health Centre,undefined
来源
Acta Neuropathologica | 2016年 / 131卷
关键词
FGFR signaling; Brain development; Molecular etiology; Whole-exome sequencing; Epilepsy; Targeted therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Dysembryoplastic neuroepithelial tumor (DNET) is a benign brain tumor associated with intractable drug-resistant epilepsy. In order to identify underlying genetic alterations and molecular mechanisms, we examined three family members affected by multinodular DNETs as well as 100 sporadic tumors from 96 patients, which had been referred to us as DNETs. We performed whole-exome sequencing on 46 tumors and targeted sequencing for hotspot FGFR1 mutations and BRAF p.V600E was used on the remaining samples. FISH, copy number variation assays and Sanger sequencing were used to validate the findings. By whole-exome sequencing of the familial cases, we identified a novel germline FGFR1 mutation, p.R661P. Somatic activating FGFR1 mutations (p.N546K or p.K656E) were observed in the tumor samples and further evidence for functional relevance was obtained by in silico modeling. The FGFR1 p.K656E mutation was confirmed to be in cis with the germline p.R661P variant. In 43 sporadic cases, in which the diagnosis of DNET could be confirmed on central blinded neuropathology review, FGFR1 alterations were also frequent and mainly comprised intragenic tyrosine kinase FGFR1 duplication and multiple mutants in cis (25/43; 58.1 %) while BRAF p.V600E alterations were absent (0/43). In contrast, in 53 cases, in which the diagnosis of DNET was not confirmed, FGFR1 alterations were less common (10/53; 19 %; p < 0.0001) and hotspot BRAF p.V600E (12/53; 22.6 %) (p < 0.001) prevailed. We observed overexpression of phospho-ERK in FGFR1 p.R661P and p.N546K mutant expressing HEK293 cells as well as FGFR1 mutated tumor samples, supporting enhanced MAP kinase pathway activation under these conditions. In conclusion, constitutional and somatic FGFR1 alterations and MAP kinase pathway activation are key events in the pathogenesis of DNET. These findings point the way towards existing targeted therapies.
引用
收藏
页码:847 / 863
页数:16
相关论文
共 510 条
  • [1] Bae JH(2010)Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells Proc Natl Acad Sci USA 107 2866-2871
  • [2] Boggon TJ(2013)Epilepsy surgery in Neurofibromatosis Type 1 Epilepsy Res 105 384-395
  • [3] Tome F(2014)A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors Acta Neuropathol 128 39-54
  • [4] Mandiyan V(2013)Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression Brain Pathol 23 574-583
  • [5] Lax I(2007)A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases Mol Cell 27 717-730
  • [6] Schlessinger J(2013)STAR: ultrafast universal RNA-seq aligner Bioinformatics 29 15-21
  • [7] Barba C(2016)B-Raf inhibition in the clinic: present and future Annu Rev Med 67 29-43
  • [8] Jacques T(2010)Inhibition of mutated, activated BRAF in metastatic melanoma N Engl J Med 363 809-819
  • [9] Kahane P(2013)Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas Acta Neuropathol 125 659-669
  • [10] Polster T(2012)Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth Am J Hum Genet 91 597-607